This inventor holds 1 USPTO granted patent. Top assignee: Pharis Biotec Gmbh. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Hans-Jürgen Magert
Introduction
Hans-Jürgen Magert is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of serine proteinase inhibitors. His work has implications for various medical and therapeutic applications.
Latest Patents
Hans-Jürgen Magert holds a patent for a serine protease inhibitor. This invention is characterized by having a domain with four cysteines, with a sequence of 0 to 20 amino acids present between the first and second cysteines. Alternatively, the serine protease inhibitor may have a domain with six cysteines, with a sequence of 7 to 20 amino acids present between the first and second cysteines. He has 1 patent to his name.
Career Highlights
Magert is associated with Pharis Biotec GmbH, where he continues to innovate and contribute to advancements in biochemistry. His work is recognized for its potential to enhance therapeutic strategies in treating various diseases.
Collaborations
Some of his notable coworkers include Wolf-Georg Forssmann and Ludger Ständker. Their collaborative efforts have furthered research in the field and have led to significant advancements.
Conclusion
Hans-Jürgen Magert's contributions to the field of biochemistry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile